CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 9. Effects of combining GM-CSF and cytostatic agents on normal hematopoiesis. Bone marrow mononuclear cells from normal donors were treated for 120 h in the absence (Control) or presence of hydroxyurea (HU, 100 µg/ml), phenylbutyrate (PB, 1.5 mM), or bryostatin-1 (Bryo, 10-8 M) with or without GM-CSF (200 units/ml) and then washed and plated in methylcellulose. Results are the means of three separate experiments; bars, SE. Ps are as determined by ANOVA for the comparison of all treatment groups.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation